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Statement of Purpose: In trauma surgery, a fast and 
effective hemostatic agent is crucial to prevent death. The 
current used hemostatic sponges are highly effective in 
stopping the hemorrhages, however they have a limited 
stability, shape memory, and biological functionality to 
induce an efficient regenerative healing after injury1-2. 
Blood derivatives have attracted great attention as an 
inexpensive milieu of bioactive molecules (e.g., growth 
factors, cytokines), self-assembling scaffolding proteins 
(e.g., fibrinogen, fibronectin, vitronectin), and 
antimicrobial peptides (e.g., platelet factor-4) that have the 
ability to enhance angiogenesis, stem cell recruitment, and 
tissue regeneration3. Among those, platelet lysate (PL) has 
attracted great attention as a milieu of supra-physiological 
doses of biomolecules that can be easily standardized. 
However, the current PL scaffolds showed limited stability 
and weak mechanical strength, which severely limits its 
performance as a bioinstructive and hemostatic 
biomaterial. Herein, we propose the use of aldehyde-
functionalized CNC (a-CNC) that will be crosslinked 
through reversible Schiff base bonds established with the 
amine groups of PL proteins to produce a stable hemostatic 
cryogel for wound healing applications. 
Methods: PL was prepared from a pool of ten donors in 
sterilized conditions. PL-CNC cryogels were obtained 
using a simple double barrel injection system (1:1 ratio 
from Medmix, Switzerland) filled with PL in one 
compartment and with a-CNC water dispersions (1.22 to 
2.44 wt.%) in the other. After extrusion/casting into square 
molds, the cryogel precursors were placed in a freezer at -
80ºC and subsequently in the freeze-dryer until full 
cryogelation. The developed cyogels were characterized 
regarding their physicochemical and hemostatic properties 
as well as their in vitro biological performance.  
Results: PL cryogels (PL-CNC 0) solubilized immediately 
after immersion in PBS while CNC incorporation (0.61 to 
1.2 wt.%) as a strengthening crosslinker improved PL 
cryogels stability. Increasing CNC loadings gradually slow 
the PL-CNC cryogel degradation rate and increased their 
specific modulus without the loss of the intrinsic PL 
bioactive properties. Interestingly, PL-CNC cryogels 
showed a reversible deformation at over 70% strain level 
and a fast shape recovery (seconds), which enable their 
clinical application using minimal invasive strategies (e.g. 
injectable shape memory cryogel). After blood immersion, 
the PL-CNC cryogels absorb comparable volumes of blood 
at a faster rate than commercial gelatin-based hemostatic 
sponges, along with better maintenance of the original 
shape and structural integrity (Figure 1) due to their 
inherent interconnected macro-porous structure (90 vol.%) 
and high elastic nature. Moreover, nanocomposite cryogels 
biophysical (e.g. porous microstructure) and biochemical 
(e.g. growth factors and cytokines) cues allowed human 
adipose-derived stem cells (hASCs) cell survival and 
proliferation, which also had an impact on other important 
cell behaviors such as cell migration. 
 
Figure 1. Blood adsorption capacity and shape 
maintenance of PL-CNC cryogels compared to commercial 
gelatin-based hemostatic sponges. 
 
Conclusions: The developed human-based nanocomposite 
cryogels showed similar hemostatic performance and 
lower shrinkage as compared to commercial gelatin 
hemostatic sponges. Moreover, the developed cyrogels 
exhibited tunable biophysical and biochemical properties 
that favor the cell supportive cryogel properties. In 
summary, the proposed PL-CNC cryogels allow the use of 
PL not only as a source of signalling biological factors 
involved in wound healing, but also as a user-friendly off-
the-shelf hemostatic biomaterial in minimal invasive 
strategies to promote regenerative wound healing 
outcomes. 
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